Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
3
43%
Ph phase_3
1
14%
Ph phase_1
1
14%
Ph not_applicable
2
29%

Phase Distribution

1

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
3(42.9%)
Phase 3Large-scale testing
1(14.3%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(6)
Other(1)

Detailed Status

Completed6
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (14.3%)
Phase 23 (42.9%)
Phase 31 (14.3%)
N/A2 (28.6%)

Trials by Status

unknown114%
completed686%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_2

Evaluate the Efficacy and Safety of D-0120 in Primary Hyperuricemia Patients

NCT05504083
completedphase_2

Dose-finding and Safety Study of SHR4640 in Subjects With Hyperuricemia

NCT03185793
completednot_applicable

Compare the Renal Protective Effects of Febuxostat and Benzbromarone

NCT02338323
completedphase_3

Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout

NCT03100318
completedphase_2

Acute Effects of Benzbromaron on the Pulmonary Circulation

NCT02790450
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT05504083Phase 2

Evaluate the Efficacy and Safety of D-0120 in Primary Hyperuricemia Patients

Completed
NCT03185793Phase 2

Dose-finding and Safety Study of SHR4640 in Subjects With Hyperuricemia

Completed
NCT02338323Not Applicable

Compare the Renal Protective Effects of Febuxostat and Benzbromarone

Completed
NCT03100318Phase 3

Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout

Completed
NCT02790450Phase 2

Acute Effects of Benzbromaron on the Pulmonary Circulation

Completed
NCT02944214Not Applicable

Compare the Renal Protective Effects of Febuxostat and Benzbromarone in CKD Chinese Patients

Unknown
NCT02317861Phase 1

A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia Patients

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7